Nef decreases HIV-1 sensitivity to neutralizing antibodies that target the membrane-proximal external region of TMgp41.
about
HIV-1 Nef promotes infection by excluding SERINC5 from virion incorporationHIV Genome-Wide Protein Associations: a Review of 30 Years of ResearchIdentification of a cluster of HIV-1 controllers infected with low replicating virusesLv4 Is a Capsid-Specific Antiviral Activity in Human Blood Cells That Restricts Viruses of the SIVMAC/SIVSM/HIV-2 Lineage Prior to IntegrationSERINC5 protein inhibits HIV-1 fusion pore formation by promoting functional inactivation of envelope glycoproteins.Exposing HIV's weaknessesStructure-guided alterations of the gp41-directed HIV-1 broadly neutralizing antibody 2F5 reveal new properties regarding its neutralizing function.Human and murine APOBEC3s restrict replication of koala retrovirus by different mechanisms.Comparative proteomic analysis of HIV-1 particles reveals a role for Ezrin and EHD4 in the Nef-dependent increase of virus infectivity.The frantic play of the concealed HIV envelope cytoplasmic tail.HIV-1 Nef responsiveness is determined by Env variable regions involved in trimer association and correlates with neutralization sensitivityThe Nef-like effect of murine leukemia virus glycosylated gag on HIV-1 infectivity is mediated by its cytoplasmic domain and depends on the AP-2 adaptor complex.The activity of Nef on HIV-1 infectivityEffect of HIV-1 Env on SERINC5 AntagonismThe host-cell restriction factor SERINC5 restricts HIV-1 infectivity without altering the lipid composition and organization of viral particles.Localization to detergent-resistant membranes and HIV-1 core entry inhibition correlate with HIV-1 restriction by SERINC5.SERINC as a Restriction Factor to Inhibit Viral Infectivity and the Interaction with HIV.Inhibiting the Ins and Outs of HIV Replication: Cell-Intrinsic Antiretroviral Restrictions at the Plasma Membrane.HIV-1 cell-to-cell transmission and broadly neutralizing antibodies
P2860
Q24338895-28CA3FDF-B558-49FC-8396-9E0BFBF28B65Q26746070-173CCB51-F2C7-4C36-A7BD-1AE4959377FCQ28534737-388F549F-3ABC-4D91-8F0B-89F27EB082B2Q28546614-A72DBE2E-5CFB-4547-A5E1-6382C4181665Q33567639-2A9C7019-B9C5-4326-834B-FEB294B13186Q33567645-7AC53F68-759D-41D6-82F2-4D9E4C0AF7C6Q34350894-55E4D7B3-486D-4C12-9848-F4A94982324CQ35927461-B2AB31E0-10D6-4902-AA8E-8104895C208CQ36759728-52289DD8-6B43-446D-88EC-034533A75C8EQ36940646-484EE328-7BB3-488C-99F2-1DF140D54D19Q37396102-5BA38919-DA6F-440B-88B6-5D667F1BE863Q37643789-0454EFD1-B3F9-4132-A924-6780628CF416Q38218107-C0EA1B9C-45AF-4C26-9A3D-16E8D2CA9580Q38727228-65B6CF2D-B295-483E-BD22-D23A823916C4Q40142057-956224AC-4F11-4E82-BF92-4C4A4C2E00AFQ47264751-FF6355B2-219C-437D-9089-6329568BEC1BQ47550082-B156E662-B6B6-4986-A7B7-E9FE40C78F67Q47550785-BD950EF0-0ADE-4B78-B881-AF6CA4ABCF32Q57030223-12D94F5F-F4FA-4425-B6E7-56E89C2E6CE5
P2860
Nef decreases HIV-1 sensitivity to neutralizing antibodies that target the membrane-proximal external region of TMgp41.
description
2011 nî lūn-bûn
@nan
2011 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Nef decreases HIV-1 sensitivit ...... mal external region of TMgp41.
@ast
Nef decreases HIV-1 sensitivit ...... mal external region of TMgp41.
@en
Nef decreases HIV-1 sensitivit ...... mal external region of TMgp41.
@nl
type
label
Nef decreases HIV-1 sensitivit ...... mal external region of TMgp41.
@ast
Nef decreases HIV-1 sensitivit ...... mal external region of TMgp41.
@en
Nef decreases HIV-1 sensitivit ...... mal external region of TMgp41.
@nl
prefLabel
Nef decreases HIV-1 sensitivit ...... mal external region of TMgp41.
@ast
Nef decreases HIV-1 sensitivit ...... mal external region of TMgp41.
@en
Nef decreases HIV-1 sensitivit ...... mal external region of TMgp41.
@nl
P2093
P2860
P50
P1433
P1476
Nef decreases HIV-1 sensitivit ...... mal external region of TMgp41.
@en
P2093
Heinrich Göttlinger
Massimo Pizzato
Rachel P J Lai
P2860
P304
P356
10.1371/JOURNAL.PPAT.1002442
P577
2011-12-15T00:00:00Z